Wang Donglin, male, Professor, Chief Physician, MD, Doctoral student supervisor; Director of Oncology Department of Chongqing Cancer Hospital, Chief Expert of Colorectal Cancer, Director of Teaching and Research Office of Internal Medicine Base, "Shaci Famous Doctor" of 2018. He received his Bachelor's Degree from the Third Military Medical University in 1985, and Master's Degree in Medicine from the Third Military Medical University in 1990 and Doctor's Degree in Medicine from the Third Military Medical University in 1994. He has served as the Deputy Director of Tumor Center of Xinqiao Hospital Affiliated to the Third Military Medical University, Director of Tumor Department of Tongji Hospital Affiliated to Shanghai Tongji University and Director of Tumor Department of Sichuan People's Hospital. He is a current Member of Chemotherapy Special Committee of China Anti-cancer Association, Cancer Rehabilitation and Palliative Treatment Special Committee of China Anti-cancer Association, Director of Cancer Clinical Research Association of Southern China, Member of Cancer Special Committee of China Doctor Association, Member of Cancer Special Committee of China Association of Traditional Chinese Medicine, Member of Standing Committee of West China Lung Cancer Research Cooperation Center, Vice Chairman of Chemotherapy Special Committee of Chongqing Anti-cancer Association, Vice Chairman of Chongqing Cancer Medical Quality Control Center, Vice Chairman of Cancer Rehabilitation and Palliative Treatment Special Committee of Chongqing Anti-cancer Association, Vice Chairman of Molecular Targeted Treatment Special Committee of Chongqing Anti-cancer Association, Vice Chairman of Palliative Treatment Special Committee of Chongqing Association of Traditional Chinese and Western Medicine, Vice Chairman of Minimally Invasive and Interventional Treatment Special Committee of Chongqing Association of Traditional Chinese and Western Medicine, Cancer Special Committee of Chongqing Association of Traditional Chinese and Western Medicine, reviewer of National Natural Science Foundation of China and Standing editorial board member of Chinese Pharmacy. He has successively won 7 National Natural Science Funds and presided over a number of provincial and ministerial scientific research projects, 1 second prize of Military Science and Technology Progress Award, 1 second prize of Chongqing Science and Technology Bureau, edited 1 monograph, published more than 70 academic papers including SCI and national core journals. Rich experience clinical work of oncology. Specialty: chemotherapy and molecular targeted treatment of cancer, especially in the diagnosis and treatment of cancer such as colorectal cancer, lung cancer and gastric cancer.